Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide is a dual agonist it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously
The indirect causes, glycogen depletion, dietary changes, blood sugar normalization, are also shared across medications that produce significant weight loss and metabolic improvement
Third, the discovery that MOTS-c also plays roles in immune regulation, particularly in suppressing innate immune overactivation, has opened research directions in inflammation-driven aging, autoimmunity, and potentially long-term sequelae of infections
J Thorac Oncol
Tirzepatide debe suspenderse cuando se reconozca un embarazo, y debe discutir con su mdico el momento adecuado para suspender el medicamento antes de un embarazo planificado